| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4520736
Max Phase: Preclinical
Molecular Formula: C18H15N5O2S
Molecular Weight: 365.42
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: COc1ccc(NC(=O)c2csc(Nc3cccc4[nH]ncc34)n2)cc1
Standard InChI: InChI=1S/C18H15N5O2S/c1-25-12-7-5-11(6-8-12)20-17(24)16-10-26-18(22-16)21-14-3-2-4-15-13(14)9-19-23-15/h2-10H,1H3,(H,19,23)(H,20,24)(H,21,22)
Standard InChI Key: FNOYPKNOFWTOCK-UHFFFAOYSA-N
Associated Targets(Human)
HDQ-P1 (69 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 365.42 | Molecular Weight (Monoisotopic): 365.0946 | AlogP: 4.02 | #Rotatable Bonds: 5 |
| Polar Surface Area: 91.93 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.37 | CX Basic pKa: 2.24 | CX LogP: 3.40 | CX LogD: 3.40 |
| Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.50 | Np Likeness Score: -2.19 |
References
| 1. Rabea SM, Baradaran-Heravi A, Balgi AD, Krause A, Hosseini Farahabadi S, Roberge M, Grierson DS.. (2019) 2-Aminothiazole-4-carboxamides Enhance Readthrough of Premature Termination Codons by Aminoglycosides., 10 (5): [PMID:31097990] [10.1021/acsmedchemlett.8b00610] |
Source
Source(1):